Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

McGill University

$17,500.00

Assessing the downstream effects of synthetic extracellular vesicles on the metastatic cascade

FY 2023-24

Summary
While we can generally control primary cancer, the spread of cancer (metastasis) proves to be a substantial clinical challenge and the leading cause of cancer-related deaths worldwide. Virtually all cells, including cancer cells, release small lipid-based particles called extracellular vesicles (EVs), which play a key role in the communication between cells. By transferring their cargo to cells of the tumour microenvironment, mounting evidence suggests that cancer cell-derived EVs selectively target specific organs for metastasis and alter the behaviour of recipient cells. However, studying these particles is difficult due to time-consuming isolation processes with low yield. Our lab has developed a synthetic system using lipid-based nanoparticles (liposomes) to mimic cancer cell-derived EVs and to study cancer metastasis. These synthetic EV-like particles can be engineered to carry cancer proteins so we can study their function during metastasis. We hypothesise that synthetic EV-like particles, when loaded with proteins from cancer EVs, are internalised by microenvironmental cells, and induce similar effects in these cells as actual cancer EVs. To test this, we will synthesise the particles using a technique that involves nano-sized droplet formation on a 3D-printed chip. During this process, proteins can be added and encapsulated into the lumen or inserted in the lipid membrane of the liposomes to create synthetic EVs. We can then test their effects on recipient cells. We believe that our EV-like particles, which closely resemble particles produced by cancer cells, will deliver their proteomic cargo and alter the behaviour of recipient cells. This synthetic model will accelerate our understanding of cancer metastasis and the role of tumour EVs.
Program
Master's Award: Canada Graduate Scholarships
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
506562
Name
Wu Tad
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Assessing the downstream effects of synthetic extracellular vesicles on the metastatic cascade
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cell Death; Colorectal Cancer; Extracellular Vesicles; Invasion; Metastasis; Migration; Nanoparticles; Proliferation; Uptake; Viability
Abstract
While we can generally control primary cancer, the spread of cancer (metastasis) proves to be a substantial clinical challenge and the leading cause of cancer-related deaths worldwide. Virtually all cells, including cancer cells, release small lipid-based particles called extracellular vesicles (EVs), which play a key role in the communication between cells. By transferring their cargo to cells of the tumour microenvironment, mounting evidence suggests that cancer cell-derived EVs selectively target specific organs for metastasis and alter the behaviour of recipient cells. However, studying these particles is difficult due to time-consuming isolation processes with low yield. Our lab has developed a synthetic system using lipid-based nanoparticles (liposomes) to mimic cancer cell-derived EVs and to study cancer metastasis. These synthetic EV-like particles can be engineered to carry cancer proteins so we can study their function during metastasis. We hypothesise that synthetic EV-like particles, when loaded with proteins from cancer EVs, are internalised by microenvironmental cells, and induce similar effects in these cells as actual cancer EVs. To test this, we will synthesise the particles using a technique that involves nano-sized droplet formation on a 3D-printed chip. During this process, proteins can be added and encapsulated into the lumen or inserted in the lipid membrane of the liposomes to create synthetic EVs. We can then test their effects on recipient cells. We believe that our EV-like particles, which closely resemble particles produced by cancer cells, will deliver their proteomic cargo and alter the behaviour of recipient cells. This synthetic model will accelerate our understanding of cancer metastasis and the role of tumour EVs.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Wu, Tad
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~